The U.S. Department of Health and Human Services (HHS) is undergoing a significant restructuring that will lead to the loss of 20,000 jobs. This decision, announced by Secretary Robert F. Kennedy Jr., aims to streamline the agency, which currently employs about 82,000 people. The cuts will bring the workforce down to 62,000.
This move includes a reduction in force of 10,000 positions alongside layoffs from employees who accepted early retirement offers. The restructuring will also consolidate HHS’s divisions from 28 to 15, which officials believe will help the agency better focus on its core mission of public health.
Kennedy stated that this change is part of a broader effort to realign HHS with its goals of combating chronic diseases. He emphasized that the agency will operate more efficiently and at a lower cost to taxpayers. The reorganization will create a new Administration for a Healthy America, which will aim to coordinate chronic care and disease prevention programs more effectively.
The job cuts will impact various divisions, including 3,500 positions at the Food and Drug Administration (FDA), 2,400 at the Centers for Disease Control and Prevention (CDC), and 1,200 at the National Institutes of Health (NIH). However, Kennedy assured that critical roles related to drug and food safety would not be affected.
These cuts are projected to save HHS $1.8 billion from its nearly $2 trillion budget, primarily used for Medicare and Medicaid benefits. This restructuring aligns with President Trump’s vision of reducing the size of the federal government, a plan that has gained traction under the leadership of Elon Musk and his Department of Government Efficiency.
While some support the cuts as a necessary step towards efficiency, others express concern about the potential negative impacts on public health. Critics, including Senator Angela Alsobrooks from Maryland, argue that such drastic reductions could endanger lives by undermining health services.
HHS employees are feeling anxious about the future, with many fearing for their jobs and the overall effectiveness of the agency. Reports indicate that morale is low, especially at the NIH, where employees worry about the future of their research and public health initiatives.
As HHS prepares for these changes, the debate continues over the balance between efficiency and the need for a robust public health workforce. The cuts and restructuring will take effect in the coming months, leaving many to wonder how this will shape the future of health services in the United States.